The contraceptives market is experiencing positive growth as a result of increased awareness about sexually transmitted diseases, an increase in government initiatives for population control, an increase in unintended pregnancies, and technological innovations leading to effective contraception, all of which are contributing to the contraceptives market's growth during the forecast period
LAS VEGAS, Aug. 23, 2023 /PRNewswire/ -- DelveInsight's Contraceptives Market Insights report provides the current and forecast market analysis, individual leading contraceptives companies' market shares, challenges, contraceptives market drivers, barriers, trends, and key market contraceptives companies in the market.
Key Takeaways from the Contraceptives Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global contraceptives market during the forecast period.
- Notable contraceptives companies such as Teva Pharmaceutical Industries Ltd, TherapeuticsMD, Inc., AbbVie Inc., Bayer AG, The Cooper Companies Inc., FemCap Inc, Veru Inc., Meril Life Sciences Pvt. Ltd., Pregna International Limited., Reckitt Benckiser Group PLC., Viatris Inc., EUROGINE, S.L, Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., Contech Devices Private Limited, Cupid Limited, and several others, are currently operating in the contraceptives market.
- In July 2023, the FDA cleared Opill (norgestrel) for non-prescription use. Opill is the first non-prescription daily oral contraceptive licensed for use in the United States.
- In June 2023, Gedeon Richter UK Ltd, a multinational pharmaceutical business, announced the acquisition of complete marketing and distribution rights to a branded generic contraception range.
To read more about the latest highlights related to the contraceptives market, get a snapshot of the key highlights entailed in the Global Contraceptives Market Report
Contraceptives Overview
Contraceptives are a diverse range of medical methods and devices designed to prevent unintended pregnancies by interfering with the process of conception. These tools help individuals and couples make informed choices about their reproductive health, allowing them to plan and space pregnancies according to their personal preferences and circumstances. Contraceptives can come in various forms, including hormonal options such as birth control pills, patches, and injections, as well as barrier methods like condoms and diaphragms. Additionally, intrauterine devices (IUDs), sterilization procedures, and fertility awareness methods offer further choices for individuals seeking effective contraception. By providing a means for people to exercise control over their reproductive choices, contraceptives play a crucial role in promoting sexual and reproductive health, empowering individuals to lead fulfilling lives while making informed decisions about their family planning.
Contraceptives Market Insights
North America is predicted to account for the greatest share of the global contraceptives market among all regions. Because of the increased prevalence of sexually transmitted diseases, there will be an increase in demand for contraceptives for avoiding sexually transmitted infections, resulting in an overall boost in contraceptives market growth. An increase in unwanted pregnancies increases the need for contraception, resulting in an increase in the overall market growth of contraceptives. Furthermore, increased abortion rates in the United States will raise demand for oral contraceptives, resulting in an overall increase in the growth of the contraceptives market.
To know more about why North America is leading the market growth in the contraceptives market, get a snapshot of the Contraceptives Market Outlook
Contraceptives Market Dynamics
The contraceptives market is seeing increased product demand for a variety of reasons. The growing public knowledge of sexually transmitted diseases (STDs) is a major driving force in the contraceptives market. Sexually Transmitted Diseases (STDs) are the most frequent infectious disease in most nations, especially among people aged 15 to 50. Furthermore, the global STI burden is linked to eight major illnesses, which include syphilis, gonorrhea, chlamydia, and human papillomavirus (HPV), among others. The danger of these infections stems from their capacity to persist without constantly displaying symptoms, as well as their high likelihood of changing into other, more lethal diseases.
Furthermore, another significant reason driving the increasing demand for contraceptives is the increased emphasis of governments and international organizations on popularising population control, which is projected to fuel contraceptive demand during the forecast period.
However, contraceptive side effects and tight regulations for IUDs, vaginal rings, and others may be limiting factors in the contraceptives market growth.
Additionally, the spread of the COVID-19 infection has had an impact on the expansion of the contraceptives market. To limit the spread of COVID infections and save human lives from novel coronaviruses, most countries are implementing lockdown and social separation laws. COVID-19 had no effect on women's capacity to use contraception because contraceptives were distributed and made available by local players in the region, such as pharmacies or government organizations. As a result, only supply chain disruptions have had a minor influence on the contraceptives market. Furthermore, with a widespread immunization campaign, the contraceptives market is predicted to grow at full capacity now and in the next years.
Get a sneak peek at the contraceptives market dynamics @ Contraceptives Market Dynamics Analysis
Report Metrics | Details |
Coverage | Global |
Study Period | 2019–2027 |
Contraceptives Market CAGR | ~5% |
Contraceptives Market Size by 2027 | USD 32.6 Billion |
Key Contraceptives Companies | Teva Pharmaceutical Industries Ltd, TherapeuticsMD, Inc., AbbVie Inc., Bayer AG, The Cooper Companies Inc., FemCap Inc, Veru Inc., Meril Life Sciences Pvt. Ltd., Pregna International Limited., Reckitt Benckiser Group PLC., Viatris Inc., EUROGINE, S.L, Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., Contech Devices Private Limited, Cupid Limited, among others |
Contraceptives Market Assessment
- Contraceptives Market Segmentation
- Contraceptives Market Segmentation By Type: Male Contraceptives, Female Contraceptives
- Contraceptives Market Segmentation By Product Type: Contraceptive Drugs [Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives {Patches, Gels, Others}], Contraceptive Devices [Condoms, Diaphragms, Cervical Caps, Vaginal Rings, Intrauterine Devices (IUDs), Subdermal Contraceptive Implants]
- Contraceptives Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the contraceptives market are set to emerge as the trendsetter explore @ Contraceptives Companies
Table of Contents
1 | Report Introduction |
2 | Executive summary |
3 | Regulatory and Patent Analysis |
4 | Key Factors Analysis |
5 | Porter's Five Forces Analysis |
6 | COVID-19 Impact Analysis on Contraceptives Market |
7 | Contraceptives Market Layout |
8 | Global Company Share Analysis – Key 3-5 Companies |
9 | Contraceptives Market Company and Product Profiles |
10 | Project Approach |
11 | About DelveInsight |
Interested in knowing the contraceptives market by 2027? Click to get a snapshot of the Contraceptives Market Trends
Related Reports
Contraceptives Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key contraceptives companies, including Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., among others.
Contraceptive Devices Market Insights, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key contraceptive devices companies, including Bayer Healthcare, Cooper Surgical Inc., Teva Pharmaceutical Industries Ltd, Reckitt Benckiser, FemCap Inc., The Female Health Company, Meril Life Sciences, Pregna International, and among others.
Contraceptive Drugs Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key contraceptive drugs companies, including Abbvie Inc, BAYER AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal Enterprises, Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare, Marlborough Pharmaceuticals, Teva Pharmaceuticals USA, Inc, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/contraceptives-global-market-exhibit-growth-at-a-cagr-of-5-by-2027--delveinsight-301907626.html
Voltar noticias em Inglês